Keep God Weird

Monday, October 6, 2008

Prostate cancer awareness

Posted: Tuesday, June 10, 2008 at 4:56 p.m.

PEORIA -- by Sarah Mason

More than 8,000 work force in Prairie State will be diagnosed with prostate gland gland gland gland malignant neoplastic disease in 2008.

Men can Step Up to the Plate and fighting prostate malignant neoplastic disease during Men's Health Week by following these tips.Discuss getting an yearly prostate-specific antigen (PSA) blood diagnostic test and digital rectal examination (DRE) with your doctor beginning at age 50.

African American work force and work force with first-degree relations (fathers, brothers, or sons) daiagnosed with prostate malignant neoplastic disease should get testing at age 40.

Here are some wellness statistics all work force should know.Men usually dwell six old age less than women.

One in four work force have got high blood pressure.

One in five work force will have a bosom onslaught before age 65.

One in six work force will develop prostate cancer.

Labels: , , , , , , , , ,


Tuesday, September 16, 2008

Gene fuels deadly prostate cancer - BBC News

A faulty factor closely associated with breast malignant neoplastic disease is also responsible for a particularly unsafe word form of prostate gland cancer, research have confirmed.

A University of Toronto squad establish prostate gland malignant neoplastic disease patients carrying the BRCA2 factor lived on norm for four old age after diagnosis.

The norm endurance clip for a adult male with prostate gland malignant neoplastic disease is 12 years.

Experts said the British Diary of Cancer survey emphasised the importance of early sensing and treatment.

It is of import that more than research is done in this country to guarantee that this grouping is targeted effectively

Dr Lesley WalkerCancer Research UK

Each twelvemonth around 35,000 new lawsuits of prostate gland malignant neoplastic disease are diagnosed in the UK, and around 10,000 work force decease from the disease

The up-to-the-minute survey - based on 301 patients - examined two closely related faulty genes, BRCA1 and BRCA2, both of which greatly increase a woman's hazard of breast cancer, and are linked to ovarian cancer.

Both factors cut mean endurance modern times in work force with prostate gland malignant neoplastic disease who carried them - for work force carrying BRCA1 the norm endurance clip was eight old age after diagnosis.

BRCA2 have already been linked to deathly prostate gland gland cancer, with an Icelandic survey recording an norm endurance clip among prostate malignant neoplastic disease patients carrying the factor of just 2.1 years.

The up-to-the-minute survey looks to corroborate that link.

Double whammy

Around one in 500 work force transport the faulty BRCA2 gene. They can be five modern times more likely than work force in the general population to develop prostate gland cancer.

Lead research worker Dr Steven Narod said: "We cognize that carrying a faulty BRCA2 factor additions a man's hazard of getting prostate gland gland cancer, and our survey shows that it also impacts how long he will last a diagnosing of the disease."

Dr Lesley Walker, of the charity Cancer Research UK, said: "Although lone a very little per centum of work force with prostate malignant neoplastic disease will transport a faulty BRCA2 gene, they're much more than likely to decease from the disease.

"It is of import that more than than research is done in this country to guarantee that this grouping is targeted effectively so malignant neoplastic disease is picked up at an early phase and, more importantly, that they are given the most appropriate treatment.

"Men with a strong household history of prostate gland or breast malignant neoplastic disease can see their general practitioner for advice."

Labels: , , , , , , , , , ,


Tuesday, September 9, 2008

Questions About Supplements and Cancer Risk

Washington, D.C. - American Institute for Cancer Research - infoZine - Why, many wonder, makes a study that golf course vegetables, fruits and whole grains with less malignant neoplastic disease hazard not impute that same protective influence to the addendums that incorporate the very nutrients and antioxidants establish in the whole foods? In addition, they ask, what harm can really be done by purchasing some further "nutritional insurance" from nutritionary supplements? For starters, taking a dietary addendum makes not supply the same benefits as healthful eating. The disease-fighting places ascribed to a diet that characteristics antioxidant-rich plant nutrients cannot be packaged into a pill or powder. Experts believe that it is the interaction of the vitamins, minerals and phytochemicals in these nutrients - a procedure called synergism - that supplies malignant neoplastic disease protection. Adding just a smattering of these chemical compounds to a addendum will not earn the same consequence as eating a varied plant-based diet. Although addendums can play an of import function in filling specific nutritionary gaps, they don't supply the protection that some people may anticipate - especially when it come ups to disease prevention. If these addendums worked, we would see less relative incidence of malignant neoplastic disease among those who take them, but we don't. In fact, a study issued by the National Institutes of Health (NIH) on multivitamin/mineral addendums and chronic disease bar recently concluded: "The present grounds is deficient to urge either for or against the usage [of multivitamins/minerals] by the American public." Those still convinced that they should protrude a pill "just in case" should observe that a survey published last twelvemonth in the Diary of the National Cancer Institute counsels caution. In the study, although no consequence (positive or negative) was seen between multivitamin pill consumption and hazard of localised prostate gland gland cancer, research workers saw a 32 percentage addition in hazard of advanced prostate malignant neoplastic disease among work force who used more than than seven multivitamin pills per week. This addition was also apparent among work force who took a multivitamin pill along with an individual food addendum such as as selenium, beta-carotene Oregon zinc. The impression that addendums may do more than injury than good is not new. A recently published analysis of 68 big trials involving more than than 232,000 grownups given antioxidant addendums showed either no benefit or even increased mortality with some antioxidants. Similarly, AICR's landmark report, Food, Nutrition, Physical Activity, and Cancer Prevention: a Global Perspective, concluded that there is strong and convincing grounds that beta-carotene addendums cause lung malignant neoplastic disease in smokers. The AICR study also urges on cautiousness even among those addendums that have got shown a positive consequence in reducing malignant neoplastic disease risk. Selenium supplements, for example, can probably less hazard of prostate gland cancer, according to AICR experts, but the mineral can be toxic at high doses. In addition, although the AICR study reasons that Ca addendums can probably protect against colorectal cancer, they also warn that Ca consumption beyond amounts recommended for healthy castanets (1200-1500 mgs per day) probably increases hazard of prostate gland cancer. A recent survey linking Ca addendums with hazard of bosom onslaught in aged women also raises of import questions. Are the AICR study saying, "Don't utilize supplements?" No, the study is saying not to turn to addendums for malignant neoplastic disease protection at this time. Certain people may profit from addendums in ways unrelated to malignant neoplastic disease risk, including: People at hazard for B-12 deficiency, including work force and women over age 50 and vegans who devour no animate being nutrients at all; pregnant women with increased folic acid needs; those at hazard for vitamin Vitamin Vitamin D deficiency, namely people who are dark-skinned or unrecorded in northern latitudes, as well as the elderly, breastfeeding women and exclusively breastfed infants; people at hazard for osteoporosis may necessitate Ca and vitamin D supplements, too.

Labels: , , , , , , , , , ,


Monday, September 1, 2008

Mediterranean diet 'cuts cancer' - BBC News

Adopting just a couple of elements of the Mediterranean Sea diet could cut the hazard of malignant neoplastic disease by 12%, state scientists.

A survey of 26,000 Grecian people establish just using more than olive oil alone cut the hazard by 9%.

The diet, studies the British Diary of Cancer, also includes higher amounts of fruits, vegetables, cereals, and less redness meat.

A separate survey establish adding Brassica oleracea italica to repasts might assist work force vulnerable to prostate gland malignant neoplastic disease cut their risk.

It demoes there are a figure of things you tin do, and there is no 1 'superfood' that can halt you developing the disease

Sara HiomCancer Research UK

The Mediterranean Sea diet came under examination after research workers noticed less rates of unwellnesses such as as as bosom disease in states such as Kingdom Of Spain and Greece.

They noticed that people living there generally ate more than veggies and fish, less reddish meat, cooked in olive oil and drank moderate amounts of alcohol.

The up-to-the-minute survey is one of the biggest yet to look at the possible impact on malignant neoplastic disease of the assorted parts of this diet.

'No superfood'

Researchers from Harvard University University persuaded one thousands of Grecian people of assorted ages to enter their nutrient consumption over an eight-year-period.

Broccoli may assist ward off prostate gland cancer

Their attachment to the Mediterranean Sea diet was ranked using a scoring system, and the grouping with the worst mark compared with those who followed a couple of facets of the diet, and those who followed it the most closely.

The greatest consequence they establish - a 9% decrease in hazard - was achieved simply by eating more than "unsaturated" fats such as as olive oil.

But just two alterations - eating less redness meat, and more than peas, edible beans and lentils, cut the hazard of malignant neoplastic disease by 12%.

Dr Dimitrios Trichopoulos, who led the study, said: "Adjusting one's overall dietary wonts towards the traditional Mediterranean Sea form had an of import effect."

Sara Hiom, from Cancer Research UK, said the research highlighted the importance of a healthy balanced diet.

"It demoes there are a figure of things you tin do, and there is no 1 'superfood' that can halt you developing the disease."

Broccoli benefit

The other survey suggesting that nutrient had the powerfulness to forestall malignant neoplastic disease came from the Institute of Food Research in Norwich.

Scientists compared the personal effects of adding 400 grammes of Brassica oleracea italica or peas a hebdomad to the diet of work force at high hazard of prostate gland gland malignant neoplastic disease - and in the lawsuit of Brassica oleracea italica establish differences in the activity of factors in the prostate which other surveys have got linked to cancer.

Their determinations raised the possibility that broccoli, or other "cruciferous" vegetables, such as as Brassica oleracea botrytis and Bruxelles sprouts, could assist forestall or slow down the disease, particularly if the adult male had a peculiar factor discrepancy - GSTM1.

Professor Richard Mithen, who led the research, published in the Populace Library of Science journal, said: "Eating two or three parts of cruciferous veggies per week, and maybe a few more than if you miss the GSTM1 factor - should be encouraged."

Professor Karol Sikora, medical manager of CancerPartnersUK, said the survey was the first clip in a properly controlled clinical trial that Brassica oleracea italica had been shown to change the look of specific factors in the prostate secretory organ gland.

"Although the observation time period was too short and the Numbers too little to demo that the relative incidence of malignant neoplastic disease actually fell, it is the first clear presentation that Brassica oleracea italica and presumably other cruciferous veggies may well cut down malignant neoplastic disease risk."

Labels: , , , , , , , , ,


Wednesday, March 19, 2008

Soya can prevent prostate cancer

NEW
YORK: A chemical compound establish in soys looks to forestall spreading of human prostate
cancer, according to the latest
research. Researchers state that
the measure of the chemical, an antioxidant known as genistein, used in the
experiments was what a human would normally eat in a soyabean-rich
diet. Investigators from
Northwestern University establish that Genistein was establish to diminish metastasis of
prostate malignant neoplastic disease to the lungs by 96 percent, compared with mice that did not eat
the chemical compound in their chow, Science
Daily reported. "These impressive
results give us trust that genistein might demo some consequence in preventing the
spread of prostate gland malignant neoplastic disease in patients," said the study's senior investigator,
Raymond C. Bergan of the Northwestern
University. "Certain chemicals
have good personal effects and now we have got got all the pre-clinical studies we necessitate to
suggest genistein might be a very promising chemo-preventive drug," said
Bergan. Bergan and his team
have previously demonstrated in prostate gland gland malignant neoplastic disease cell civilizations that genistein
inhibits withdrawal of malignant neoplastic disease cells from a primary prostate tumour and represses
cell invasion. It makes this by
blocking activation of p38 map kinases, molecules which modulate nerve pathways that
activate proteins that loosen malignant neoplastic disease cells from their tight clasp within a
tumour, pushing them to migrate. Investigators fed genistein to
several groupings of mice before implanting them with an aggressive word form of
prostate cancer. The amount of genistein in the blood of the animate beings was
comparable to human blood concentrations after ingestion of soybean foods, Bergan
said. The research workers found
that while genistein didn't cut down the size of tumors that developed within the
prostate, it stopped lung metastasis almost completely. They repeated the
experiment and establish the same
result. These determinations have
been published in March issue of Cancer
Research

Labels: , , , , , , , , ,



Digg ItDel.icio.us
Furl ItReddit
My WebNewsvine
WistsBlogmarks
RSS ATOM
Web Pages referring to this page
Link to this page and get a link back!

Archives

June 2007 September 2007 November 2007 December 2007 January 2008 February 2008 March 2008 April 2008 May 2008 September 2008 October 2008 November 2008 December 2008 January 2009 February 2009 March 2009 September 2009 October 2009

This page is powered by Blogger. Isn't yours?